Odyssey Therapeutics (ODTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $17.57, +5.84% vs the prior close of $16.60.
- Volume 159.00K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ODTX jumps 5.8% to $17.57. Closed at $17.57, +5.84% vs the prior close of $16.60. Day range $16.36–$17.75, opened at $16.62.
ODTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ODTX jumps 5.8% to $17.57
- Closed at $17.57, +5.84% vs the prior close of $16.60. Day range $16.36–$17.75, opened at $16.62.
- Volume was 159.00K shares, 0.6x its 50-day average of 278.17K — lighter than usual.
- Price is -21.6% vs its 50-day average ($22.40).
- 52-week range $15.10–$29.05; today's close sits at 18% of that range, 39.5% below the 52-week high.
Oct 14, 2026 — ODTX slides 3.7% to $16.60, a 3-month low, 3 down days in a row
- Closed at $16.60, -3.71% vs the prior close of $17.24. Day range $16.51–$17.35, opened at $16.87.
- Volume was 245.60K shares, 0.9x its 50-day average of 275.97K.
- Price is -26.1% vs its 50-day average ($22.47).
- 52-week range $15.10–$29.05; today's close sits at 11% of that range, 42.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — ODTX slides 5.6% to $17.24, a 1-month low
- Closed at $17.24, -5.59% vs the prior close of $18.26. Day range $17.18–$18.40, opened at $18.15.
- Volume was 258.80K shares, 0.9x its 50-day average of 273.62K.
- Price is -23.5% vs its 50-day average ($22.53).
- 52-week range $15.10–$29.05; today's close sits at 15% of that range, 40.7% below the 52-week high.
Oct 12, 2026 — ODTX slides 3.9% to $18.26
- Closed at $18.26, -3.89% vs the prior close of $19.00. Day range $18.16–$19.15, opened at $18.88.
- Volume was 282.70K shares, 1.0x its 50-day average of 271.63K.
- Price is -19.0% vs its 50-day average ($22.55).
- 52-week range $15.10–$29.05; today's close sits at 23% of that range, 37.1% below the 52-week high.
Oct 9, 2026 — ODTX jumps 4.9% to $19.00
- Closed at $19.00, +4.86% vs the prior close of $18.12. Day range $18.49–$19.65, opened at $18.72.
- Volume was 325.60K shares, 1.2x its 50-day average of 267.26K.
- Price is -15.8% vs its 50-day average ($22.56).
- 52-week range $15.10–$29.05; today's close sits at 28% of that range, 34.6% below the 52-week high.
Oct 8, 2026 — ODTX ends flat (+0.2%) to $18.12
- Closed at $18.12, +0.22% vs the prior close of $18.08. Day range $17.13–$18.38, opened at $17.83.
- Volume was 414.20K shares, 1.6x its 50-day average of 262.98K.
- Price is -19.7% vs its 50-day average ($22.55).
- 52-week range $15.10–$29.05; today's close sits at 22% of that range, 37.6% below the 52-week high.
Oct 7, 2026 — ODTX ends flat (-0.3%) to $18.08, a 1-month low
- Closed at $18.08, -0.28% vs the prior close of $18.13. Day range $17.83–$18.84, opened at $18.01.
- Volume was 264.10K shares, 1.0x its 50-day average of 260.49K.
- Price is -19.8% vs its 50-day average ($22.55).
- 52-week range $15.10–$29.05; today's close sits at 21% of that range, 37.8% below the 52-week high.
Oct 6, 2026 — ODTX slides 13.0% to $18.13, a 1-month low
- Closed at $18.13, -13.00% vs the prior close of $20.84. Day range $18.06–$20.84, opened at $20.84.
- Volume was 340.70K shares, 1.3x its 50-day average of 256.86K.
- Price is -19.6% vs its 50-day average ($22.56).
- 52-week range $15.10–$29.05; today's close sits at 22% of that range, 37.6% below the 52-week high.
Oct 5, 2026 — ODTX rises 0.5% to $20.84
- Closed at $20.84, +0.53% vs the prior close of $20.73. Day range $19.73–$20.96, opened at $20.52.
- Volume was 171.80K shares, 0.7x its 50-day average of 256.65K.
- Price is -7.7% vs its 50-day average ($22.58).
- 52-week range $15.10–$29.05; today's close sits at 41% of that range, 28.3% below the 52-week high.
Oct 2, 2026 — ODTX rises 1.5% to $20.73
- Closed at $20.73, +1.52% vs the prior close of $20.42. Day range $20.05–$21.60, opened at $20.67.
- Volume was 192.50K shares, 0.8x its 50-day average of 255.82K.
- Price is -8.0% vs its 50-day average ($22.53).
- 52-week range $15.10–$29.05; today's close sits at 40% of that range, 28.6% below the 52-week high.
ODTX latest news & SEC filings
Every SEC filing by or about ODTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 9, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $959.00K) (-100.0% vs Jun 30, 2025)
- Net income: -$52.79M (prior year -$41.23M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.74 (prior year -$29.54) (loss narrowed vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade ODTX
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: Jun 17, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.37% (largest 13.0%). That is a volatile stock.
- Liquidity: about 400.33K shares (≈$7.03M) trade per day on average.
- 52-week position: $17.57 vs a range of $15.10–$29.05 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 14 open-market buys, 6 sales; latest: James G Coulter bought 1,388,889 shares on May 11, 2026.
- Latest filings: 8-K Sep 9, 2026; 10-Q Aug 6, 2026; 8-K Aug 4, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
ODTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 16.62 | 17.75 | 16.36 | 17.57 | 159.00K |
| Oct 14, 2026 | 16.87 | 17.35 | 16.51 | 16.60 | 245.60K |
| Oct 13, 2026 | 18.15 | 18.40 | 17.18 | 17.24 | 258.80K |
| Oct 12, 2026 | 18.88 | 19.15 | 18.16 | 18.26 | 282.70K |
| Oct 9, 2026 | 18.72 | 19.65 | 18.49 | 19.00 | 325.60K |
| Oct 8, 2026 | 17.83 | 18.38 | 17.13 | 18.12 | 414.20K |
| Oct 7, 2026 | 18.01 | 18.84 | 17.83 | 18.08 | 264.10K |
| Oct 6, 2026 | 20.84 | 20.84 | 18.06 | 18.13 | 340.70K |
| Oct 5, 2026 | 20.52 | 20.96 | 19.73 | 20.84 | 171.80K |
| Oct 2, 2026 | 20.67 | 21.60 | 20.05 | 20.73 | 192.50K |
| Oct 1, 2026 | 21.98 | 22.36 | 20.33 | 20.42 | 308.40K |
| Sep 30, 2026 | 22.48 | 23.50 | 21.70 | 22.22 | 334.20K |
| Sep 29, 2026 | 21.47 | 22.76 | 21.21 | 22.44 | 201.70K |
| Sep 28, 2026 | 20.02 | 21.65 | 19.72 | 21.47 | 213.10K |
| Sep 25, 2026 | 19.90 | 20.88 | 19.41 | 20.51 | 237.80K |
| Sep 24, 2026 | 20.77 | 21.09 | 18.77 | 19.93 | 396.00K |
| Sep 23, 2026 | 22.99 | 23.03 | 20.53 | 20.76 | 255.20K |
| Sep 22, 2026 | 23.36 | 24.33 | 22.70 | 23.34 | 555.20K |
| Sep 21, 2026 | 24.51 | 25.22 | 23.05 | 23.06 | 245.70K |
| Sep 18, 2026 | 23.35 | 25.15 | 22.88 | 24.38 | 2.60M |
About Odyssey Therapeutics
Odyssey Therapeutics (ODTX) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in BOSTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1882782.
ODTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Shelley Chu | Director | May 11, 2026 |
| Capital Ii, L.P. Dimension | Director | May 12, 2026 |
| Gary D Glick | See Remarks | May 11, 2026 |
| Paulina Hill | Director | May 7, 2026 |
| Jeffrey M Leiden | Director | May 11, 2026 |
| Nan (Ln) Li | Director | May 11, 2026 |
| Carolyn Ng | Director | May 7, 2026 |
| Valerie Odegard | Director | May 11, 2026 |
| Aranicki Ksenija Pavletic | Director | May 7, 2026 |
| Ian F Smith | Director | May 11, 2026 |
| Ourania Tatsis | Director | May 11, 2026 |
| Timothy P Walbert | Director | May 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Natalie Dales | See Remarks | May 11, 2026 |
| Gary D Glick | See Remarks | May 11, 2026 |
| Jason Haas | Chief Financial Officer | May 11, 2026 |
| Anthony W. Opipari | See Remarks | May 11, 2026 |
| Jolie Siegel | See Remarks | May 7, 2026 |
| Collin M Todd | See Remarks | May 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 11, 2026 | James G Coulter | Buy | 1,388,889 | $18.00 |
| May 11, 2026 | Jon Winkelried | Buy | 1,388,889 | $18.00 |
| May 11, 2026 | Gp A, Llc Tpg | Buy | 1,388,889 | $18.00 |
| May 11, 2026 | Shelley Chu | Buy | 11,111 | $18.00 |
| May 11, 2026 | Nan (Ln) Li | Buy | 1,111,111 | $18.00 |
| May 11, 2026 | Simeon George | Buy | 200,000 | $18.00 |
| May 11, 2026 | Simeon George | Sale | 1,065 | $18.00 |
| May 11, 2026 | Simeon George | Buy | 222,222 | $18.00 |
| May 11, 2026 | Simeon George | Sale | 277 | $18.00 |
| May 11, 2026 | Simeon George | Buy | 133,333 | $18.00 |
| May 11, 2026 | Simeon George | Sale | 438 | $18.00 |
| May 11, 2026 | One Capital Management, Llc Sr | Buy | 200,000 | $18.00 |
| May 11, 2026 | One Capital Management, Llc Sr | Sale | 1,065 | $18.00 |
| May 11, 2026 | One Capital Management, Llc Sr | Buy | 222,222 | $18.00 |
| May 11, 2026 | One Capital Management, Llc Sr | Sale | 277 | $18.00 |
ODTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $483.85M, total liabilities $62.63M, cash $82.03M (as of Jun 30, 2026).
ODTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $19.96 |
| Jun 17, 2026 | 8-K Item 2.02 (results) | $18.48 |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ODTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.